Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, United States.
Department of Cell and Developmental Biology, University of Colorado School of Medicine, Aurora, United States.
Elife. 2019 Jul 31;8:e47246. doi: 10.7554/eLife.47246.
Cytoplasmic dynein plays critical roles within the developing and mature nervous systems, including effecting nuclear migration, and retrograde transport of various cargos. Unsurprisingly, mutations in dynein are causative of various developmental neuropathies and motor neuron diseases. These 'dyneinopathies' define a broad spectrum of diseases with no known correlation between mutation identity and disease state. To circumvent complications associated with dynein studies in human cells, we employed budding yeast as a screening platform to characterize the motility properties of seventeen disease-correlated dynein mutants. Using this system, we determined the molecular basis for several classes of etiologically related diseases. Moreover, by engineering compensatory mutations, we alleviated the mutant phenotypes in two of these cases, one of which we confirmed with recombinant human dynein. In addition to revealing molecular insight into dynein regulation, our data provide additional evidence that the type of disease may in fact be dictated by the degree of dynein dysfunction.
细胞质动力蛋白在发育和成熟的神经系统中发挥着关键作用,包括影响核迁移和各种货物的逆行运输。毫不奇怪,动力蛋白的突变是各种发育性神经病变和运动神经元疾病的原因。这些“动力蛋白病”定义了一个广泛的疾病谱,突变的身份与疾病状态之间没有已知的相关性。为了避免与人类细胞中动力蛋白研究相关的并发症,我们利用芽殖酵母作为筛选平台来描述十七种与疾病相关的动力蛋白突变体的运动特性。使用该系统,我们确定了几种病因相关疾病的分子基础。此外,通过工程补偿突变,我们缓解了其中两种情况下的突变表型,其中一种我们用人重组动力蛋白进行了确认。除了揭示动力蛋白调节的分子见解外,我们的数据还提供了额外的证据,表明疾病的类型实际上可能取决于动力蛋白功能障碍的程度。